Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-056585
Filing Date
2020-12-09
Accepted
2020-12-09 17:25:34
Documents
2
Effectiveness Date
2020-12-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A abio-defa14a_20201209.htm DEFA14A 39368
2 GRAPHIC gh4jibiaz1pt000001.jpg GRAPHIC 3922
  Complete submission text file 0001564590-20-056585.txt   46144
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 201378692
SIC: 2835 In Vitro & In Vivo Diagnostic Substances